96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Short synthetic peptide and uses thereof
#2102Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2103Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2104Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2105Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2106PEPTIDES
#2107Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
#2108Peptides and combination of peptides for use in immunotherapy against various tumors
#2109PEPTIDES DERIVED FROM P ANTIGEN FAMILY MEMBER 2 (PAGE2)
#2110PEPTIDES
#2111Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2112ANTI-TUMOUR RESPONSE TO MODIFIED SELF-EPITOPES
#2113Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#2114Peptides and uses therefor as antiviral agents
#2115PEPTIDES FROM PIWIL1
#2116PEPTIDES
#2117METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF
#2118FOXM1-derived peptide, and vaccine including same
#2119Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2120Transfection complexes and methods of using the same
#2121Peptides and combination of peptides for use in immunotherapy against various tumors
#2122METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM
#2123Method for producing a composition for treating a tooth lesion
#2124PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1
#2125PD-1 and CTLA-4 dual inhibitor peptides
#2126PEPTIDOMIMETIC MACROCYCLES
#2127Collagenase-derived peptides promote tissue regeneration and wound healing
#2128Artificial nucleases including engineered FokI cleavage half-domains
#2129NPR-B agonists
#2130PEPTIDES
#2131Methods and products for in vivo enzyme profiling
#2132Surfactant adhesive composition
#2133NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2134Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#2135Formulation of modified interleukin-7 fusion protein
#2136PEPTIDE PHARMACEUTICALS
#2137HER-2-SPECIFIC CYCLIZED SUPR PEPTIDES
#2138COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY
#2139Composition for improving memory, learning ability, and cognitive ability
#2140Purification method, purification kit, and silicon oxide-binding tag for use therein
#2141MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#2142N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
#2143CD200 inhibitors and methods of use thereof
#2144EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO
#2145Neuroprotective peptides
#2146Serpin reactive center loop peptides and methods of use
#2147Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#2148Cyclic peptide binder against oncogenic K-Ras
#2149Antimicrobial peptide and use thereof
#2150Gelatinase inhibitors and use thereof
#2151PSMA-specific binding proteins
#2152Therapy and kit for the prevention and treatment of cystic fibrosis
#2153STABILIZED BIOACTIVE PEPTIDES AND METHODS OF IDENTIFICATION, SYNTHESIS, AND USE
#2154Integrin binding peptides and uses thereof
#2155ENDOSOMAL ESCAPE PEPTIDES
#2156Method of treating Alzheimer's disease
#2157METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS AND COMPOSITIONS CONTAINING SAME
#2158Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use
#2159Kinin-based theranostic probes for solid cancers and uses thereof
#2160Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
#2161Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#2162Method of treating melanocortin-4 receptor pathway-associated disorders
#2163Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
#2164Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
#2165COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS
#2166Melanocortin Receptor Ligands
#2167Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers
#2168Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#2169Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#2170Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#2171Interferon analogs
#2172Compositions and methods for managing respiratory conditions
#2173Inhibitors of NF κ-B activity for treatment of diseases and disorders
#2174Compounds with dual activity
#2175Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
#2176Peptide pharmaceuticals
#2177Use of peptides to stimulate the immune system
#2178Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies
#2179Peptides and combination thereof for use in the immunotherapy against cancers
#2180Methods and compositions for the treatment of arthritis
#2181One-bead-two-compound macrocyclic library and methods of preparation and use
#2182Peptides of use in the preventive and curative treatment of alopecia
#2183COATING FOR METAL NANOPARTICLES
#2184Compounds having RD targeting motifs and methods of use thereof
#2185Claudin-18.2-specific immunoreceptors and T cell epitopes
#2186Peptide-based inhibitors of MLL/SET1 family core complexes
#2187Kinase substrates and methods of use thereof
#2188Protein based adhesive composition and method
#2189NEW METHODS FOR MAKING BARUSIBAN AND ITS INTERMEDIATES
#2190Compositions and methods related to inhibition of respiratory syncytial virus entry
#2191Butelase-mediated peptide ligation
#2192Medical Use
#2193HER2 peptide regents and methods
#2194Anti-androgen peptides and uses thereof in cancer therapy
#2195P75antagonists and treatment of acute and chronic cardiac disease
#2196THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR FLAVIVIRUSES
#2197Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES
#2198Compounds for medicinal applications
#2199Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting
#2200Immune checkpoint inhibitor combinations
#2201RELAXIN1 derived peptides for use in immunotherapy against various tumors
#2202System and method for identification and characterization of transglutaminase species
#2203CCR2 antagonist peptides
#2204Peptides and combination of peptides for use in immunotherapy against various tumors
#2205NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2206Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2207Oxadiazole cyclic peptides
#2208Anti-endotoxin polypeptide
#2209CEACAM based antibacterial agents
#2210Anti-PVRIG antibodies and methods of use
#2211Heme peptide materials for anti-inflammatory regenerative nanobiomedicine
#2212Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
#2213AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#2214Targeted delivery system and methods of use therefor
#2215Drug-conjugates, conjugation methods, and uses thereof
#2216Specifically purified anti-presepsin antibody
#2217Anti-Aggrus monoclonal antibody, domain in Aggrus which is required for binding to CLEC-2, and method for screening for Aggrus-CLEC-2 binding inhibitor
#2218Anti-CK8 antibodies for use in the treatment of colorectal cancers
#2219Peptides and combination of peptides for use in immunotherapy against various tumors
#2220Peptides and combination of peptides for use in immunotherapy against various tumors
#2221Cell-permeable bone morphogenetic protein (CP-BMP) recombinant protein and use thereof
#2222Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, DNA, and vector
#2223Peptide conjugates
#2224ANTISENSE COMPOSITIONS TARGETING ERWINIA SPECIES AND METHODS OF USING THE SAME
#2225MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#2226SINGLE-CHAIN OX40-RECEPTOR AGONIST PROTEINS
#2227Peptides and combination of peptides for use in immunotherapy against various tumors
#2228Peptides and combination of peptides for use in immunotherapy against various tumors
#2229Compounds, compositions and uses thereof for improvement of bone disorders
#2230Selective recovery
#2231Cyclic peptide, affinity chromatography support, labeled antibody, antibody drug conjugate, and pharmaceutical preparation
#2232HYPERPOLARIZATION OF AMINO ACID RESIDUES FOR PRODUCING HYPERPOLARIZED PEPTIDES
#2233Compounds containing a vascular disrupting agent
#2234Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same
#2235Peptide for preventing or treating inflammatory diseases and use thereof
#2236Biorecognition elements for rapid detection of biocontamination
#2237Immunologically active polypeptide
#2238Nucleic acids encoding antibodies to Kallidin and des-Arg-Kallidin and host cells comprising the same
#2239DEPDC1-derived peptide and vaccine containing same
#2240MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#2241Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors
#2242Vitamin receptor drug delivery conjugates for treating inflammation
#2243METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS
#2244TWO-DIMENSIONAL STRUCTURES FROM PEPTOID OLIGOMERS AND METHODS OF MAKING
#2245Compounds and Compositions for the Treatment of Ophthalmic Disorders
#2246METHOD FOR PREPARATION OF N-ACYL PEPTIDES, POLYPEPTIDES AND PROTEINS
#2247Three-dimensional tissue scaffold with stem cell attracting element and use thereof
#2248Peptide oligonucleotide conjugates
#2249PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY
#2250Bone-targeting antibodies
#2251Peptides and combination of peptides for use in immunotherapy against various tumors
#2252Peptides and combination of peptides for use in immunotherapy against various tumors
#2253Immunogenic WT-1 peptides and methods of use thereof
#2254Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
#2255NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#2256PHARMACEUTICAL COMPOSITION THAT IS ANTICANCER AND SUPPRESSES CANCER METASTASIS, CONTAINING, AS ACTIVE INGREDIENT, FUSION PEPTIDE SIMULTANEOUSLY TARGETING CANCER CELL AND TUMOR ASSOCIATED MACROPHAGE
#2257Cell-penetrating compositions and methods using same
#2258Hydrogel-forming peptides
#2259Peptoid
#2260Bicyclic lipolantipeptide, preparation and use as antimicrobial agent
#2261COMPOSITION FOR IMPROVING MEMORY, LEARNING ABILITY, AND COGNITIVE ABILITY
#2262NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME
#2263STABILIZED PEPTIDE COMPOSITION
#2264Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
#2265INDUCTION OF TUMOR IMMUNITY BY VARIANTS OF FOLATE BINDING PROTEIN
#2266USE OF PENTAPEPTIDE-3 KTTKS OR HEXAPEPTIDE-3 KTTKSF FOR TREATING DEGENERATIVE JOINT DISEASE
#2267Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#2268Immunotherapy against melanoma and other cancers
#2269Peptide for skin regeneration or wound treatment and use thereof
#2270Peptides and compositions for prevention of cell adhesion and methods of using same
#2271Anti-cancer peptide and use thereof
#2272Coupled peptide chain for dissolving poorly soluble polypeptides and application thereof for separation and purification in liquid chromatography
#2273Peptide
#2274Cell penetrating peptides for intracellular delivery of molecules
#2275BACE1 inhibitor peptides
#2276Antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated, and use thereof
#2277LIGAND-CYTOTOXIC DRUG CONJUGATE, PREPARATION METHOD THEREOF, AND USE THEREOF
#2278Methods of treating cancer using compounds containing a vascular disrupting agent
#2279Epitope for switching to T17 cell and use thereof
#2280STAPLED PEPTIDES AND USES THEREOF
#2281Peptide having antimicrobial activity against pathogens and antimicrobial peptide composition comprising the same
#2282Peptides and analogs for use in the treatment of oral mucositis
#2283Conotoxin peptide κ-CPTX-BTL04, preparation method therefor, and uses thereof
#2284Partner of SLD five 1 (PSF1)-derived peptide
#2285HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
#2286Stabilized minimal coiled-coil mimetics
#2287Cahuitamycins and methods of making and using the same
#2288Adiponectin peptidomimetics for treating ocular disorders
#2289Fluorescent substrates for determining lysine modifying enzyme activity
#2290Inhibitors of prototypic galectin dimerization and uses thereof
#2291Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics
#2292Peptidomimetics for imaging the ghrelin receptor
#2293Cancer cell-targeting peptide and use thereof
#2294AGENT HAVING ANTI-ICE NUCLEATION ACTIVITY
#2295Delivering CRISPR therapeutics with lipid nanoparticles
#2296Multitarget-directed bio-inorganic hybrid structure
#2297NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
#2298Cardiovascular Therapeutics
#2299Peptide derivative for regulating thymic stromal lymphoid protein-mediated signaling and pharmaceutical composition for preventing and treating allergy and asthma diseases comprising same
#2300Prodrugs of peptide epoxy ketone protease inhibitors
#2301Bone fracture repair by targeting of agents that promote bone healing
#2302TUMOR ANTIGEN PEPTIDE
#2303Oligopeptide having proinflammatory cytokine secretion-inhibiting activity
#2304Inhibitors of mitochondrial fission and methods of use thereof
#2305Peptides and combination of peptides for use in immunotherapy against various tumors
#2306Synthetic antimicrobial peptides
#2307Compositions and methods for inhibiting CD279 interactions
#2308Pentapeptide associated with integrin receptor alpha vbeta3
#2309Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders
#2310Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay
#2311PAR1 and PAR2 c-tail peptides and peptide mimetics
#2312Peptide and its derivatives capable of inhibiting replication of hepatitis V virus in human adipose-derived stem cells and hepatocytes
#2313Inhibition of gliadin peptides
#2314Peptide and composition containing the same for anti-inflammation, anti-fibrosis, wound healing, and anticancer treatment
#2315Methods and systems for measuring plasma renin activity
#2316NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#2317Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
#2318Anti-HIV peptides
#2319RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
#2320Immunotherapy against several tumors including gastrointestinal and gastric cancer
#2321Therapeutic peptides for cerebrovascular diseases
#2322Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
#2323Bi-functional arginine-glycine-aspartic acid (RGD) peptides and methods to promote angiogenesis
#2324Intracellular organelle peptide targeted enzyme substrates
#2325Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
#2326Influenza virus neutralizing peptidomimetic compounds
#2327MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN
#2328Peptide with anti-obesity and anti-diabetes activity and use thereof
#2329CDCA1 epitope peptides for Th1 cells and vaccines containing the same
#2330Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#2331Anti-microbial supramolecular structures
#2332Calcium binding compounds based on gamma-carboxy glutamate
#2333IL-23-p19 vaccines
#2334Peptide with anti-aging effect and use thereof
#2335Cyclic monomer and dimer peptides having integrin antagonist activity
#2336Melanocortin Receptor Ligands
#2337Oxidative modification improves the drugability of cell penetrating peptides as drug carriers
#2338Polypeptides, peptides, and proteins functionalized by alkylation of thioether groups via ring-opening reactions
#2339Novel linker, preparation method, and application thereof
#2340Targeting GIV-GEF-GI signaling for treating diverse diseases
#2341Peptides and combination of peptides for use in immunotherapy against various tumors
#2342Short synthetic peptide for treating diseases and/or conditions related to angiogenesis
#2343Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases
#2344Peptides and combination of peptides for use in immunotherapy against various tumors
#2345CELL PENETRATING PEPTIDES & METHODS OF IDENTIFYING CELL PENETRATING PEPTIDES
#2346METHODS OF TREATING OPHTHALMIC DISEASES USING NPR-B AGONISTS
#2347Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
#2348Mechanically interlocking complexes
#2349INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#2350Bioactive peptides having insecticide activity
#2351PHARMACEUTICAL COMPOUND
#2352Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient
#2353Adhesive peptide and use therefor
#2354Compositions for overcoming anti-cancer drug-resistance or compositions for anti-cancer activity employing CAGE-derived peptides
#2355TRPV3 agonists for the treatment of skin conditions
#2356Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
#2357CDCA1-derived peptide and vaccine containing same
#2358Solution phase method for preparing etelcalcetide
#2359Adiponectin peptidomimetics for treating ocular disorders
#2360Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#2361Stable and soluble antibodies inhibiting VEGF
#2362Cancer stem cell targeting peptide and use thereof
#2363Mutant Akt-specific capture agents, compositions, and methods of using and making
#2364Peptides and compositions comprising same and uses thereof in the treatment of diseases
#2365Influenza Virus Binding Peptides
#2366Alpha connexin c-terminal (ACT) peptides and methods of use thereof
#2367PRO-APOPTOTIC SET AND PP2A PEPTIDES
#2368NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#2369CXCR4 antagonists and methods of use
#2370CONFORMATIONALLY STABLE ANALOGS OF THE RESPONSE SELECTIVE C5A AGONIST EP67
#2371CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#2372Compositions for treating pathological calcification conditions, and methods using same
#2373Compositions for treating pathological calcification conditions, and methods using same
#2374Compositions for treating pathological calcification conditions, methods, and host cells using the same
#2375Ang (1-7) derivative oligopeptides and methods for using and producing the same
#2376Peptides capable of reactivating p53 mutants
#2377Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
#2378MUC1-DERIVED PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER, IMMUNITY-INDUCING AGENT AND METHOD FOR MANUFACTURING ANTIGEN PRESENTING CELL USING SAME
#2379Water-soluble peptide fluorescence material
#2380Claudin-1 peptide reagents and methods
#2381Compounds, substrates and methods related to histone deacetylases
#2382Methods of identifying biologically active random peptides in plants and libraries of plants expressing candidate biologically active random peptides
#2383Methods for displaying cyclic peptides on bacteriophage particles
#2384Anti-microbial peptides and coatings
#2385Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#2386Method and peptides for the detection of
#2387Peptide
#2388Co-assembly peptides, nanostructures, and methods of making and using the same
#2389URLC10-derived peptide and vaccine containing same
#2390Peptides and combination of peptides for use in immunotherapy against various tumors
#2391NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2392Peptides and combination of peptides for use in immunotherapy against various tumors
#2393Peptides and combination of peptides for use in immunotherapy against various tumors
#2394Peptides for the treatment of malignant proliferative diseases
#2395Treatment agent for cognitive impairment induced by amyloid beta-protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these
#2396Peptides and combination of peptides for use in immunotherapy against various tumors
#2397Minor histocompatibility antigens and uses thereof
#2398COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR USE IN VASCULAR INTERVENTION
#2399Non-membrane disruptive P53 activating stapled peptides
#2400MCJ agonists and uses therefor